NeuroPace (NPCE) Tops Q3 EPS by 9c

NeuroPace (NASDAQ: NPCE) reported Q3 EPS of ($0.11), $0.09 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $27.4 million versus the consensus estimate of $24.31 million.

For earnings history and earnings-related data on NeuroPace (NPCE) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• JetBlue Vacations adds theme park experts for Orlando bookings
• Truist: 'We remain bullish on AdaptHealth (AHCO) post management meetings'